These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1444485)

  • 1. [A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
    Ohsawa S; Kondo Y; Shiroto H; Masuko H; Fukushima T; Kataoka A; Ohmori K; Sawaguchi Y; Baba E; Takahashi T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2189-93. PubMed ID: 1444485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
    Suda Y; Uchida K; Okamura H; Oshima Y; Shimizu M; Miyakawa T; Okubo S; Shiina E; Hosoda Y; Tokura Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2181-7. PubMed ID: 1444484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
    Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
    Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
    Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].
    Sakamoto K; Arita S; Hisikawa E; Yaguchi H; Arima H; Matsumoto M; Hachisu T; Kashiwabara H; Yokoyama T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):239-44. PubMed ID: 7857099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os].
    Yamamoto Y; Amano T; Fujimoto Y; Imada T; Tamura S; Noguchi Y; Matsumoto A
    Gan No Rinsho; 1987 Apr; 33(4):377-81. PubMed ID: 3106673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
    Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
    Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
    Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S; Baccanari DP; Joyner SS; Davis ST; Rustum YM; Spector T
    Cancer Res; 1995 Dec; 55(24):6227-30. PubMed ID: 8521418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pre- and post-operative adjuvant chemotherapy of colorectal cancer. Part 1. Drug concentration in tissues following UFT administration].
    Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Fukuda Y; Eida K; Ishii T; Kotake Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3239-43. PubMed ID: 3143310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
    Arima S; Futami K; Shigeta M; Kinashi M; Shimura H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
    Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
    Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of combined oral uracil and ftorafur.
    Ho DH; Covington WP; Pazdur R; Brown NS; Kuritani J; Newman RA; Raber MN; Krakoff IH
    Drug Metab Dispos; 1992; 20(6):936-40. PubMed ID: 1362949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.